XGEN.DE vs. XSX6.DE
XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) and XSX6.DE (Xtrackers STOXX Europe 600 UCITS ETF) are both exchange-traded funds - XGEN.DE is a Health & Biotech Equities fund tracking the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100, while XSX6.DE is a Europe Equities fund tracking the STOXX® Europe 600. Both are passively managed. Over the past 3 years, XGEN.DE returned 1.39%/yr vs 13.95%/yr for XSX6.DE. A 0.54 correlation means they provide meaningful diversification when combined. XGEN.DE charges 0.30%/yr vs 0.20%/yr for XSX6.DE.
Performance
XGEN.DE vs. XSX6.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XGEN.DE achieves a -1.40% return, which is significantly lower than XSX6.DE's 7.40% return.
XGEN.DE
- 1D
- 3.92%
- 1M
- 6.45%
- YTD
- -1.40%
- 6M
- -3.78%
- 1Y
- 22.37%
- 3Y*
- 1.39%
- 5Y*
- —
- 10Y*
- —
XSX6.DE
- 1D
- 0.59%
- 1M
- 0.87%
- YTD
- 7.40%
- 6M
- 10.04%
- 1Y
- 16.19%
- 3Y*
- 13.95%
- 5Y*
- 9.70%
- 10Y*
- 9.14%
XGEN.DE vs. XSX6.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.40% | 7.38% | 2.95% | -5.84% | -9.98% |
XSX6.DE Xtrackers STOXX Europe 600 UCITS ETF | 7.40% | 20.91% | 8.35% | 15.54% | 1.49% |
Correlation
The correlation between XGEN.DE and XSX6.DE is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.52 |
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022 | 0.54 |
The correlation between XGEN.DE and XSX6.DE has been stable across timeframes, ranging from 0.51 to 0.54 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XGEN.DE vs. XSX6.DE — Risk / Return Rank
XGEN.DE
XSX6.DE
XGEN.DE vs. XSX6.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) and Xtrackers STOXX Europe 600 UCITS ETF (XSX6.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XGEN.DE | XSX6.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.04 | ||
| Sortino ratioReturn per unit of downside risk | -0.02 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.24 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.49 | 1.73 | -0.24 |
| Martin ratioReturn relative to average drawdown | 3.61 | 6.55 | -2.94 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XGEN.DE | XSX6.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.23 | 1.26 | -0.04 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.66 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.58 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.11 | 0.59 | -0.70 |
Drawdowns
XGEN.DE vs. XSX6.DE - Drawdown Comparison
The maximum XGEN.DE drawdown since its inception was -37.58%, roughly equal to the maximum XSX6.DE drawdown of -36.05%. Use the drawdown chart below to compare losses from any high point for XGEN.DE and XSX6.DE.
Loading charts...
Drawdown Indicators
| XGEN.DE | XSX6.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.58% | -36.05% | -1.53% |
Max Drawdown (1Y)Largest decline over 1 year | -14.99% | -9.46% | -5.53% |
Max Drawdown (3Y)Largest decline over 3 years | -28.21% | -16.37% | -11.84% |
Max Drawdown (5Y)Largest decline over 5 years | — | -20.84% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -36.05% | — |
Current DrawdownCurrent decline from peak | -14.86% | -1.56% | -13.30% |
Average DrawdownAverage peak-to-trough decline | -19.44% | -5.27% | -14.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.19% | 2.50% | +3.69% |
Volatility
XGEN.DE vs. XSX6.DE - Volatility Comparison
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) has a higher volatility of 6.48% compared to Xtrackers STOXX Europe 600 UCITS ETF (XSX6.DE) at 4.26%. This indicates that XGEN.DE's price experiences larger fluctuations and is considered to be riskier than XSX6.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XGEN.DE | XSX6.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.48% | 4.26% | +2.22% |
Volatility (6M)Calculated over the trailing 6-month period | 13.73% | 10.73% | +3.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.19% | 12.95% | +5.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.66% | 14.44% | +4.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.66% | 15.61% | +3.05% |
XGEN.DE vs. XSX6.DE - Expense Ratio Comparison
XGEN.DE has a 0.30% expense ratio, which is higher than XSX6.DE's 0.20% expense ratio.
Dividends
XGEN.DE vs. XSX6.DE - Dividend Comparison
Neither XGEN.DE nor XSX6.DE has paid dividends to shareholders.
Frequently Asked Questions
XGEN.DE and XSX6.DE have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XSX6.DE is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XSX6.DE is cheaper with a 0.20% expense ratio, compared with 0.30% for XGEN.DE.
XGEN.DE is categorized as Health & Biotech Equities, while XSX6.DE is Europe Equities. XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100, while XSX6.DE tracks STOXX® Europe 600. Their fees differ too: 0.30% for XGEN.DE and 0.20% for XSX6.DE.
Find the right allocation for XGEN.DE and XSX6.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer